BRK-B vs JMM

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.

JMM presents a classic deep-value profile, with a Piotroski F-Score of 6/9 indicating stable financial health and a current price ($5.78) trading at a significant discount to both its Graham Number ($8.63) and Intrinsic Value ($14.07). While valuation metrics are highly attractive—specifically a P/E of 11.56 against a sector average of 35.49—the asset is hampered by a completely bearish technical trend (0/100) and weak insider sentiment (40/100). The fund shows decent earnings growth (14.1%), but the extreme disconnect between intrinsic value and market price suggests a value trap or a lack of market catalyst. Overall, it is a strong candidate for income-focused value investors, but a risky bet for growth or momentum traders.